Inventor · disambiguated record
Rafi Emmanuel
Also filed as: EMMANUEL RAFI
11 granted patents·27 pending applications·3 citations·filing 2017–2025
80Inventor score
Top patents by PatentIndex Score
38 records- 0184US11827879B2Differential knockout of an allele of a heterozygous bestrophin 1 geneEMENDOBIO INC·Filed 2018·Granted Nov 28, 2023·3 cites·11 claims
- 0276US2025057988A1Guide RNA That Targets A Mutant Human Guanylate Cyclase 2A AlleleEMENDOBIO INC·Filed 2024·Application pending·0 cites
- 0374US2024229024A9Compositions for genome editingEMENDOBIO INC·Filed 2023·Application pending·0 cites
- 0473US2024132881A1Differential knockout of an allele of a heterozygous bestrophin 1 geneEMENDOBIO INC·Filed 2023·Application pending·0 cites
- 0572US2024384306A1Compositions And Methods For Promoting Gene Editing of CXCR4 GeneEMENDOBIO INC·Filed 2024·Application pending·0 cites
- 0665US12480140B2Differential knockout of an allele of a heterozygous ELANE geneEMENDOBIO INC·Filed 2019·Granted Nov 25, 2025·0 cites·12 claims
- 0764US12435334B2Differential knockout of an allele of a heterozygous ELANE gene-IIEMENDOBIO INC·Filed 2020·Granted Oct 7, 2025·0 cites·7 claims
- 0863US12359196B2Differential knockout of an allele of a heterozygous fibrinogen alpha chain (FGA) geneEMENDOBIO INC·Filed 2018·Granted Jul 15, 2025·0 cites·3 claims
- 0961US12168062B2Guide RNA that targets a mutant human guanylate cyclase 2A alleleEMENDOBIO INC·Filed 2018·Granted Dec 17, 2024·0 cites·6 claims
- 1060US12258599B2Method to inactivate a mutant allele of an ELANE geneEMENDOBIO INC·Filed 2020·Granted Mar 25, 2025·0 cites·8 claims
- 1160US2025283115A1Engineered high fidelity omni-50 nuclease variantsEMENDOBIO INC·Filed 2022·Application pending·0 cites
- 1260US2025043260A1Engineered High Activity Omni-79 Nuclease VariantsEMENDOBIO INC·Filed 2022·Application pending·0 cites
- 1360US2024350665A1Hepatitis b virus (hbv) knockoutsEMENDOBIO INC·Filed 2022·Application pending·0 cites
- 1460US2025277202A1Knockout of a mutant allele of an elane geneEMENDOBIO INC·Filed 2025·Application pending·0 cites
- 1559US11795453B2Compositions for genome editingEMENDOBIO INC·Filed 2017·Granted Oct 24, 2023·0 cites·19 claims
- 1659US2020123542A1Rna compositions for genome editingEMENDOBIO INC·Filed 2019·Application pending·0 cites
- 1757US2025017970A1Reduced Expression of Sarm1 For Use In Cell TherapyEMENDOBIO INC·Filed 2022·Application pending·0 cites
- 1856US12031149B2Compositions and methods for promoting gene editing of CXCR4 geneEMENDOBIO INC·Filed 2020·Granted Jul 9, 2024·0 cites·12 claims
- 1956US2024175035A1Compositions and methods for treating hypercholesterolemiaEMENDOBIO INC·Filed 2022·Application pending·0 cites
- 2055US2025018056A1Strategies for knock-ins at c3 safe harbor sitesEMENDOBIO INC·Filed 2022·Application pending·0 cites
- 2155US2024175013A1Biallelic knockout of tracEMENDOBIO INC·Filed 2021·Application pending·0 cites
- 2254US12274758B2Guide RNA that targets a mutant human inosine monophosphate deyhydrogenase I alleleEMENDOBIO INC·Filed 2018·Granted Apr 15, 2025·0 cites·6 claims
- 2354US2024042025A1Biallelic knockout of b2mIZHAR LIOR·Filed 2021·Application pending·0 cites
- 2451US2024000970A1Differential knockout of a heterozygous allele of lrrk2EMENDOBIO INC·Filed 2021·Application pending·0 cites
- 2551US2019330620A1Rna compositions for genome editingEMENDOBIO INC·Filed 2017·Application pending·0 cites
- 2650US2022136013A1Differential knockout of a heterozygous allele of stat1EMENDOBIO INC·Filed 2020·Application pending·0 cites
- 2750US2023212562A1Differential knockout of a heterozygous allele of samd9lEMENDOBIO INC·Filed 2021·Application pending·0 cites
- 2849US12454705B2Differential knockout of an allele of a heterozygous apolipoprotein A1 (APO1A) geneEMENDOBIO INC·Filed 2019·Granted Oct 28, 2025·0 cites·14 claims
- 2949US2023287428A1Biallelic knockout of sarm1EMENDOBIO INC·Filed 2021·Application pending·0 cites
- 3049US2022154157A1New engineered high fidelity cas9EMENDOBIO INC·Filed 2020·Application pending·0 cites
- 3148US11274288B2Compositions and methods for promoting homology directed repair mediated gene editingEMENDOBIO INC·Filed 2017·Granted Mar 15, 2022·0 cites·20 claims
- 3248US2022387515A1Differential knockout of an allele of a heterozygous elane gene using guides 21-30 nucleotides in lengthBARAM DAVID·Filed 2020·Application pending·0 cites
- 3348US2022307057A1Crispr compositions and methods for promoting gene editing of gata2BARAM DAVID·Filed 2020·Application pending·0 cites
- 3448US2022267777A1Differential knockout of a heterozygous allele of rpe65BARAM DAVID·Filed 2020·Application pending·0 cites
- 3547US2022098621A1Crispr compositions and methods for promoting gene editing of ribosomal protein s19 (rps19) geneEMENDOBIO INC·Filed 2020·Application pending·0 cites
- 3647US2023332146A1Differential knockout of a heterozygous allele of samd9EMMANUEL RAFI·Filed 2021·Application pending·0 cites
- 3747US2022064635A1Crispr compositions and methods for promoting gene editing of adenosine deaminase 2 (ada2)EMENDOBIO INC·Filed 2020·Application pending·0 cites
- 3842US2023173105A1Differential knockout of an allele of a heterozygous rhodopsin geneEMENDOBIO INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rafi Emmanuel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →